Latest Insider Transactions at Sotera Health CO (SHC)
This section provides a real-time view of insider transactions for Sotera Health CO (SHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sotera Health Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sotera Health Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 22
2024
|
Michael B. Petras Jr. Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
39,243
+50.0%
|
-
|
|
Nov 22
2024
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Bona fide gift
|
Indirect |
39,243
-0.75%
|
-
|
|
Nov 20
2024
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
29,250
-4.18%
|
$380,250
$13.21 P/Share
|
|
Nov 20
2024
|
Michael P Rutz President of Sterigenics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,889
-0.53%
|
$37,557
$13.21 P/Share
|
|
Sep 10
2024
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Bona fide gift
|
Indirect |
200,000
-3.67%
|
-
|
|
Sep 06
2024
|
Warburg Pincus & Co. Director |
SELL
Open market or private sale
|
Indirect |
30,000,000
-16.89%
|
$450,000,000
$15.03 P/Share
|
|
Sep 06
2024
|
Gtcr Investment Xi LLC Director |
SELL
Open market or private sale
|
Indirect |
10,000,000
-16.89%
|
$150,000,000
$15.03 P/Share
|
|
Aug 05
2024
|
Jonathan M. Lyons Sr. Vice President, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,659
-6.49%
|
$107,226
$14.22 P/Share
|
|
May 24
2024
|
Karen Flynn |
BUY
Grant, award, or other acquisition
|
Direct |
20,089
+50.0%
|
-
|
|
May 24
2024
|
Robert Brown Knauss |
BUY
Grant, award, or other acquisition
|
Direct |
20,089
+35.94%
|
-
|
|
May 24
2024
|
David E. Wheadon |
BUY
Grant, award, or other acquisition
|
Direct |
20,089
+26.48%
|
-
|
|
May 24
2024
|
James Neary |
BUY
Grant, award, or other acquisition
|
Direct |
20,089
+24.58%
|
-
|
|
May 24
2024
|
Vincent K Petrella |
BUY
Grant, award, or other acquisition
|
Direct |
20,089
+24.58%
|
-
|
|
May 24
2024
|
David Donnini |
BUY
Grant, award, or other acquisition
|
Direct |
20,089
+24.58%
|
-
|
|
May 24
2024
|
Ann R. Klee |
BUY
Grant, award, or other acquisition
|
Direct |
20,089
+15.83%
|
-
|
|
May 24
2024
|
Constantine S Mihas |
BUY
Grant, award, or other acquisition
|
Direct |
20,089
+24.58%
|
-
|
|
May 24
2024
|
Sean Laurence Cunningham |
BUY
Grant, award, or other acquisition
|
Direct |
20,089
+24.58%
|
-
|
|
May 24
2024
|
Ruoxi Chen |
BUY
Grant, award, or other acquisition
|
Direct |
20,089
+24.58%
|
-
|
|
Mar 04
2024
|
Warburg Pincus & Co. Director |
SELL
Open market or private sale
|
Indirect |
33,188,726
-15.74%
|
$464,642,164
$14.31 P/Share
|
|
Mar 04
2024
|
Gtcr Investment Xi LLC Director |
SELL
Open market or private sale
|
Indirect |
11,062,908
-15.74%
|
$154,880,712
$14.31 P/Share
|
|
Mar 04
2024
|
Jonathan M. Lyons Sr. Vice President, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
41,124
+25.83%
|
-
|
|
Mar 04
2024
|
Alexander Dimitrief SVP, General Counsel and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
51,405
+15.2%
|
-
|
|
Mar 04
2024
|
Ann R. Klee |
SELL
Open market or private sale
|
Direct |
5,750
-6.22%
|
$80,500
$14.31 P/Share
|
|
Mar 04
2024
|
Michael P Rutz President of Sterigenics |
SELL
Open market or private sale
|
Direct |
83,109
-13.24%
|
$1,163,526
$14.31 P/Share
|
|
Mar 04
2024
|
Michael P Rutz President of Sterigenics |
BUY
Grant, award, or other acquisition
|
Direct |
34,270
+5.18%
|
-
|
|
Mar 04
2024
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Open market or private sale
|
Indirect |
1,003,870
-15.55%
|
$14,054,180
$14.31 P/Share
|
|
Mar 04
2024
|
Michael B. Petras Jr. Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
274,160
+28.15%
|
-
|
|
Mar 02
2024
|
Michael P Rutz President of Sterigenics |
SELL
Payment of exercise price or tax liability
|
Direct |
5,501
-0.46%
|
$77,014
$14.56 P/Share
|
|
Mar 02
2024
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
49,564
-5.36%
|
$693,896
$14.56 P/Share
|
|
Nov 20
2023
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
29,250
-5.0%
|
$380,250
$13.93 P/Share
|
|
Nov 20
2023
|
Michael P Rutz President of Sterigenics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,911
-0.32%
|
$24,843
$13.93 P/Share
|
|
Aug 07
2023
|
Jonathan M. Lyons Sr. Vice President, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
76,967
+50.0%
|
-
|
|
May 26
2023
|
David E. Wheadon |
BUY
Grant, award, or other acquisition
|
Direct |
15,712
+30.57%
|
-
|
|
May 26
2023
|
James Neary |
BUY
Grant, award, or other acquisition
|
Direct |
15,712
+27.43%
|
-
|
|
May 26
2023
|
Vincent K Petrella |
BUY
Grant, award, or other acquisition
|
Direct |
15,712
+27.43%
|
-
|
|
May 26
2023
|
Constantine S Mihas |
BUY
Grant, award, or other acquisition
|
Direct |
15,712
+27.43%
|
-
|
|
May 26
2023
|
Ann R. Klee |
BUY
Grant, award, or other acquisition
|
Direct |
15,712
+14.52%
|
-
|
|
May 26
2023
|
Robert Brown Knauss |
BUY
Grant, award, or other acquisition
|
Direct |
15,712
+50.0%
|
-
|
|
May 26
2023
|
David Donnini |
BUY
Grant, award, or other acquisition
|
Direct |
15,712
+27.43%
|
-
|
|
May 26
2023
|
Ruoxi Chen |
BUY
Grant, award, or other acquisition
|
Direct |
15,712
+27.43%
|
-
|
|
May 26
2023
|
Sean Laurence Cunningham |
BUY
Grant, award, or other acquisition
|
Direct |
15,712
+27.43%
|
-
|
|
Mar 06
2023
|
Michael B. Petras Jr. Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
213,189
+26.72%
|
-
|
|
Mar 06
2023
|
Michael P Rutz President of Sterigenics |
BUY
Grant, award, or other acquisition
|
Direct |
28,425
+4.52%
|
-
|
|
Mar 02
2023
|
Michael P Rutz President of Sterigenics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,948
-0.51%
|
$50,116
$17.41 P/Share
|
|
Mar 02
2023
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,841
-5.07%
|
$337,297
$17.41 P/Share
|
|
Nov 20
2022
|
Michael B. Petras Jr. Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
29,251
-6.96%
|
$175,506
$6.02 P/Share
|
|
Nov 20
2022
|
Michael P Rutz President of Sterigenics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,911
-0.33%
|
$11,466
$6.02 P/Share
|
|
Nov 07
2022
|
Alexander Dimitrief SVP, General Counsel and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
235,478
+50.0%
|
-
|
|
May 27
2022
|
David Donnini |
BUY
Grant, award, or other acquisition
|
Direct |
10,643
+29.17%
|
-
|
|
May 27
2022
|
Sean Laurence Cunningham |
BUY
Grant, award, or other acquisition
|
Direct |
10,643
+29.17%
|
-
|